A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Clinical trial NCT07327619 · RECRUITING

Trial details

NCT number: NCT07327619
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

Start date: 2026-01-22
Primary completion: 2028-06-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.